The serine-threonine kinase Akt1 promotes cell survival through inhibition of apoptosis. One of the potential downstream targets of Akt1 is p70 S6 kinase, p70
INTRODUCTION
Upon exposure to various pathological conditions including cerebral ischemia two types of physiological responses have been delineated in cells of various origins: those leading to cell death and those promoting cell survival (Ouyang et al., 1999) . The balance between these responses determines the fate of the cell; thus, an understanding of both is of importance in designing protective pharmacological strategies.
The serine-threonine kinase Akt1 (also known as protein kinase B␣) is believed to be one of the proteins that mediates cell survival responses. First discovered as a protooncogen (Staal and Hartley, 1988) Akt1 has later been implicated in the antiapoptotic signaling of several growth factors (Crowder and Freeman, 1998; Dudek et al., 1997; Philpott et al., 1997) and immune receptors (Ahmed et al., 1997; Coffer et al., 1998b) , as well as in diverse metabolic reactions (Cross et al., 1995; Kohn et al., 1996; Ueki et al., 1998) . Although it is not known how Akt1 suppresses apoptosis, several studies have identified possible targets of its antiapoptotic action. Those include BAD (Datta et al., 1997; del Peso et al., 1997) and Caspase 9 (Brunet et al., 1999; Cardone et al., 1998) , which are phosphorylated and thereby inhibited once Akt1 becomes activated by upstream kinases. Another Akt1 target is p70 S6 kinase, p70 S6K , an enzyme regulating mRNA translation (Burgering and Coffer, 1995). p70 S6K is activated through multisite phosphorylation (Pullen et al., 1998) .
Activation of Akt1 is initiated by the interaction of its plecstrin homology (PH) domain with the lipid products of PI3-kinase, PtdIns(3,4)P 2 , and PtdIns(3,4,5)P 3 , which results in translocation of the kinase to the membrane. Phospholipid binding relieves the inhibitory effect of the PH domain and causes phosphorylation of Akt1 on two residues: Thr308 in the activation loop of the catalytic domain
